This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heifets, L.
Right arrow Articles by Sanchez, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heifets, L.
Right arrow Articles by Sanchez, T.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2000, p. 1498-1501, Vol. 38, No. 4
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

New Agar Medium for Testing Susceptibility of Mycobacterium tuberculosis to Pyrazinamide

Leonid Heifets* and Tracy Sanchez

National Jewish Medical and Research Center, Denver, Colorado

Received 3 September 1999/Returned for modification 27 December 1999/Accepted 25 January 2000

A new agar medium to perform pyrazinamide (PZA) susceptibility testing with Mycobacterium tuberculosis has been developed. This medium has an acidic pH of 6.0 instead of the usual for agar media, pH 6.8, to provide optimal conditions for PZA activity, and it also differs from conventional Middlebrook 7H10/7H11 agar in that animal serum (fetal or calf bovine or fetal equine serum) is used instead of oleic acid-albumin-dextrose-catalase to support good growth of M. tuberculosis at the low pH of 6.0. A critical concentration of 900 or 1,200 µg of PZA/ml in this medium made it possible to differentiate between PZA-susceptible and PZA-resistant clinical isolates. This agar medium has the following advantages compared to a liquid medium: it allows determination of the actual proportion of PZA-resistant bacteria in the isolate and it is simple and inexpensive. In addition, it has the potential of being used for a direct susceptibility test with PZA, but this approach will require further confirmation. Further studies to develop critical concentrations of other drugs for this low-pH medium, as well as to investigate the possibility of cultivation in regular (non-CO2) incubators, are in progress.

* Corresponding author. Mailing address: 1400 Jackson St., Denver, CO 80206. Phone: (303) 398-1384. Fax: (303) 398-1953. E-mail: heifetsl{at}njc.org.

Journal of Clinical Microbiology, April 2000, p. 1498-1501, Vol. 38, No. 4
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Gumbo, T., Siyambalapitiyage Dona, C. S. W., Meek, C., Leff, R. (2009). Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs. Antimicrob. Agents Chemother. 53: 3197-3204 [Abstract] [Full Text]  
  • Martin, A., Takiff, H., Vandamme, P., Swings, J., Palomino, J. C., Portaels, F. (2006). A new rapid and simple colorimetric method to detect pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide. J Antimicrob Chemother 58: 327-331 [Abstract] [Full Text]  
  • Singh, A., Gupta, R., Vishwakarma, R. A., Narayanan, P. R., Paramasivan, C. N., Ramanathan, V. D., Tyagi, A. K. (2005). Requirement of the mymA Operon for Appropriate Cell Wall Ultrastructure and Persistence of Mycobacterium tuberculosis in the Spleens of Guinea Pigs. J. Bacteriol. 187: 4173-4186 [Abstract] [Full Text]  
  • Takii, T., Hamasaki, S., Hirano, K., Abe, C., Onozaki, K. (2005). Simple Fibroblast-Based Assay To Test the Pyrazinamide Susceptibility of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49: 804-807 [Abstract] [Full Text]  
  • Madison, B., Gross, W., George, I., Sloutsky, A., Washabaugh, G., Robinson-Dunn, B., Lipman, H., Metchock, B., Mazurek, G., Ridderhof, J. (2002). Multicenter Evaluation of a Nonweekend Reading Schedule for Radiometric Pyrazinamide Susceptibility Testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 40: 3753-3756 [Abstract] [Full Text]  
  • ZHANG, Y., PERMAR, S., SUN, Z. (2002). Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. J Med Microbiol 51: 42-49 [Abstract] [Full Text]  
  • Joloba, M. L., Bajaksouzian, S., Jacobs, M. R. (2000). Evaluation of Etest for Susceptibility Testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 38: 3834-3836 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»